Compare Manchester United PLC (MANU) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manchester United PLC vs Zoetis Inc — how do they compare? Manchester United PLC trades at $20.51 (market cap $3.51B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 8.6× Manchester United PLC's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Manchester United PLC for 109 Days and Zoetis Inc for 70 Days on average.
| MANU | ZTS | |
|---|---|---|
Market Cap | $3.51B | $30.20B |
Volume | 412,769 | 6,175,327 |
Sector | Media | Health |
52-Week High | $24.19 | $147.53 |
52-Week Low | $15.20 | $69.09 |
Typical Hold Time | 109 Days | 70 Days |
Enterprise Value | $4.33B | $37.76B |
Dividend Yield | 1.26% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Manchester United (MANU) trades at $20.32, up 0.35% on the day, with a bearish technical signal from moving averages and neutral oscillators. The company reported a net loss of $33.02 million for 2025, with revenue of $666.51 million, and has a negative net income margin of -6.34%. Recent news highlights a valuation gap, with the market cap of $3.6 billion seen as a discount to Forbes' $7.2 billion franchise estimate.
The outlook is mixed; improved revenue and Champions League qualification offer upside, but persistent losses and high debt pose risks. Analyst sentiment is cautious with a 40% buy, 60% hold consensus. Key catalysts include profitability improvements and franchise value realization, while execution risks and league-wide financial pressures remain concerns.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
